Form 483

Natures Soy, LLC dba Keystone Natural Holdings, LLC Bolder Division Form 483, 2009-06-24

FDA issued a Form 483 to Natures Soy, LLC dba Keystone Natural Holdings, LLC Bolder Division on 2009-06-24 with 6 public-safe observations.

483· Form 483 issued6 observations

Natures Soy, LLC dba Keystone Natural Holdings, LLC Bolder Division · Boulder, United States · Issued June 24, 2009

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

24 Jun 2009
21 CFR 110.20(b)(4)

Drip and condensate

Cited by Marie B Buen-Bigornia, Kimberley A Hoefen, Bryan J Love

24 Jun 2009
21 CFR 110.20(b)(6)

Fans/air blowing equipment

Cited by Marie B Buen-Bigornia, Kimberley A Hoefen, Bryan J Love

24 Jun 2009
21 CFR 110.35(c)

Lack of effective pest exclusion

Cited by Marie B Buen-Bigornia, Kimberley A Hoefen, Bryan J Love

24 Jun 2009
21 CFR 110.37(e)(4)

Devices and fixtures

Cited by Marie B Buen-Bigornia, Kimberley A Hoefen, Bryan J Love

24 Jun 2009
21 CFR 110.40(a)

Precluding contaminants

Cited by Marie B Buen-Bigornia, Kimberley A Hoefen, Bryan J Love

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 110.20(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 110.20(b)(6)Cited across public-safe Form 483 observations1x
21 CFR 110.35(c)Cited across public-safe Form 483 observations1x
21 CFR 110.37(e)(4)Cited across public-safe Form 483 observations1x
21 CFR 110.40(a)Cited across public-safe Form 483 observations1x
21 CFR 110.80(b)(1)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere